Question explored with the scientific record
Create a model of pathogenesis regarding how a flu vaccine triggers warm aiha? Show me the best plausible theory from injection to injury in 2-6 week onset.
The short version: the evidence you retrieved does not contain a single study that tests whether the flu vaccine triggers warm AIHA, so the best plausible theory is a mechanism that has never been studied in humans.
The evidence you gave me is about influenza vaccine effectiveness, immune responses in mice, and general AIHA biology. None of it tests the question you asked. There is no study in this set that follows vaccinated people for 2-6 weeks and looks for new-onset warm AIHA. That gap is the finding.
The plausible mechanism is textbook immunology. A flu vaccine delivers viral antigens plus an adjuvant that activates T cells and B cells broadly [1, 9]. In a person with a predisposing genetic background or a subtle defect in B-cell tolerance (like the RAG-deficient patients in evidence [15], where AIHA is common), that activation can expand a B-cell clone that makes IgG against a red cell surface protein. The IgG coats the red cells, and the spleen destroys them extravascularly. The 2-6 week window is the time it takes for a naive B cell to go through affinity maturation and class-switch to IgG. That is the theory. It is biologically coherent. It is also untested in any study you provided.
My call: the evidence you retrieved does not answer whether the flu vaccine triggers warm AIHA. The mechanism is plausible but unstudied. Confidence: not clear, because the relevant study was never done.
Sources examined 24
-
Cell-Cultured Influenza Vaccine Enhances IFN-γ+ T Cell and Memory T Cell Responses Following A/Victoria/2570/2019 IVR-215 (A/H1N1) Infection
This study compares the immune responses elicited by cell-cultured and egg-based influenza vaccines in BALB/c mice, demonstrating that the cell-cultured vaccine significantly enhances T cell responses and offers potential advantages for long-term immunity.
DOI: 10.3390/vaccines12121392 -
Low uptake of influenza vaccine among university students: Evaluating predictors beyond cost and safety concerns
This study evaluates the low uptake of influenza vaccination among university students, identifying barriers to vaccination and the potential impact of educational interventions on increasing vaccine acceptance.
DOI: 10.1016/j.vaccine.2015.02.033 -
Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
A multicenter, randomized phase III trial in 6- to 71-month-old children with recurrent respiratory tract infections shows that cold-adapted influenza vaccine, trivalent (CAIV-T) provides superior protection against culture-confirmed influenza strains antigenically similar to th…
DOI: 10.1097/01.inf.0000237829.66310.85 -
Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development
A comprehensive, up-to-date review of the global health impact of influenza, current vaccination strategies, and the evolving role of nanotechnology in influenza vaccine development, including challenges and future directions toward universal vaccines.
DOI: 10.3390/vaccines13090890 -
Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada
This study compares the effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in preventing laboratory-confirmed influenza among children aged 2 to 17 years during the 2012-2013 to 2015-2016 influenza seasons in Alberta, Canada, findin…
DOI: 10.1001/jamapediatrics.2018.1514 -
The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia
This study evaluates the effectiveness of the trivalent inactivated influenza vaccine (TIV) in preventing hospitalizations due to laboratory-confirmed influenza in children in Western Australia, finding a vaccine effectiveness of 62.3% with low vaccine uptake.
DOI: 10.1016/j.vaccine.2015.10.122 -
Induction of Cross-Neutralizing Antibody Against H5N1 Virus After Vaccination with Seasonal Influenza Vaccine in COPD Patients
This study investigates the induction of cross-neutralizing antibodies against the H5N1 virus in elderly COPD patients following vaccination with a seasonal influenza vaccine, revealing that vaccination, rather than influenza illness, is responsible for the observed antibody res…
DOI: 10.1089/vim.2009.0082 -
Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China
This study estimates the effectiveness of the influenza vaccine against hospitalization due to influenza in Beijing during the 2015/16 season, finding that vaccination did not provide effective protection.
DOI: 10.1016/j.vaccine.2017.03.084 -
Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine
This study investigates the kinetics of viral shedding and immune responses in healthy adults following administration of the cold-adapted influenza vaccine (CAIV), revealing significant viral shedding and immune activation compared to the trivalent influenza vaccine (TIV).
DOI: 10.1016/j.vaccine.2009.09.041 -
Safety of Simultaneous Vaccination With Adjuvanted Zoster Vaccine and Adjuvanted Influenza Vaccine
A randomized, blinded clinical trial in adults aged 65 and older found that simultaneous vaccination with the adjuvanted recombinant zoster vaccine (RZV) and an adjuvanted influenza vaccine (aIIV4) has noninferior safety compared with simultaneous vaccination of RZV and high‑dos…
DOI: 10.1001/jamanetworkopen.2024.40817 -
Evaluation of influenza vaccination in health-care workers, using rapid antigen detection test
This study assesses the effectiveness of the trivalent influenza vaccine in preventing influenza and reducing absenteeism among health-care workers at Gifu Red Cross Hospital, demonstrating significant reductions in both influenza infections and work absenteeism among vaccinated…
DOI: 10.1007/s10156-005-0424-9 -
Mixed-type autoimmune haemolytic anaemia: Unusual cases and a case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma
This study presents two unusual cases of mixed-type autoimmune hemolytic anemia (AIHA), including one case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma, highlighting the diagnostic challenges and treatment responses in such conditions.
DOI: 10.1080/110245330601111466 -
Mixed Type Autoimmune Hemolytic Anemia: A Single Center Observational Study
Over two decades, a single-center retrospective analysis of 63 mixed-type autoimmune hemolytic anemia patients in Milan, Italy, reveals severe presentation, high transfusion needs, multiple therapy lines, and frequent infections and thrombosis with variable responses to steroids…
DOI: 10.1182/blood-2024-194219 -
Thermal effects on IgM-milk fat globule-mediated agglutination
This study visualizes and analyzes how IgM mediates cold agglutination of milk fat globules in raw bovine milk using confocal laser scanning microscopy and proteomics, showing storage temperature promotes agglutination while pasteurization temperatures progressively inactivate I…
DOI: 10.1017/S0022029918000778 -
Clinical, immunological features, treatments, and outcomes of autoimmune hemolytic anemia in patients with RAG deficiency
This international retrospective study presents the largest case series to date on autoimmune hemolytic anemia (AIHA) in patients with RAG deficiency, detailing clinical/immunological features, treatment responses, Evans syndrome phenotype, and the potential curative impact of a…
DOI: 10.1182/bloodadvances.2023011264 -
FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia
A comprehensive review of FcRn blockade as a targeted therapeutic strategy for IgG-driven autoimmune diseases, focusing on warm autoimmune hemolytic anemia (wAIHA) and the clinical development of Nipocalimab and other FcRn inhibitors, their mechanisms, trial results, safety, and…
DOI: 10.3390/antib14030065 -
Altered antibody repertoires of plasma IgM and IgG toward nonself antigens in patients with warm autoimmune hemolytic anemia
The study shows that patients with warm autoimmune hemolytic anemia (WAIHA) have broadly altered plasma antibody repertoires toward nonself antigens, characterized by markedly reduced IgM reactivity and distinct IgG patterns compared with healthy controls, with immunosuppressive…
DOI: 10.1016/s0198-8859(01)00225-7 -
Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review
This case report describes a 52-year-old man with warm autoimmune hemolytic anemia (AIHA) associated with renal urothelial cancer who achieved temporary hematologic improvement after nephroureterectomy, highlighting a rare paraneoplastic presentation and its clinical management.
DOI: 10.1186/s12894-015-0071-0 -
Temperature dependence of nerve conduction and EMG in neuropathy associated with gammopathy
In MGUS-associated polyneuropathy, warming the extremities to 36°C increased nerve conduction velocity and altered other neurophysiological parameters, with the warming effect correlating with post-warming CV and suggesting that warming the limb (not temperature correction) prov…
DOI: 10.1002/mus.880170508 -
Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside
This study investigates the molecular mimicry of phage displayed peptides that mimic the GD3 ganglioside, revealing their homology to self-proteins and suggesting potential applications in melanoma immunotherapy.
DOI: 10.1016/s0196-9781(99)00095-9 -
Molecular mimicry and the generation of host defense protein diversity
This study investigates the molecular mimicry and evolutionary dynamics of host defense proteins, revealing that these proteins exhibit significantly greater divergence compared to other protein classes, potentially driven by coevolution with pathogens.
DOI: 10.1016/0092-8674(93)90571-7 -
Case report: anti-fibrillarin autoantibodies induced by viral molecular mimicry in a paediatric patient
This case report describes a 14-year-old girl who developed anti-fibrillarin autoantibodies due to molecular mimicry from an Epstein-Barr virus infection, highlighting the transient nature of such autoimmune responses in pediatric patients.
DOI: 10.1186/s13052-025-02029-0 -
Molecular Mimicry between Respiratory Syncytial Virus F Antigen and the Human Proteome
This study investigates molecular mimicry between the Respiratory Syncytial Virus F antigen and the human proteome, revealing significant peptide sharing that may contribute to autoimmunity following vaccination.
DOI: 10.1055/s-0043-1761489 -
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
This study investigates the molecular mimicry between the SARS-CoV-2 spike glycoprotein and mammalian proteomes, suggesting that such mimicry may contribute to the autoimmune responses observed in COVID-19 patients.
DOI: 10.1007/s12026-020-09152-6